← Leaderboards
John Sarantopoulos
University Of Texas Hlth Science Center
$67,178
Attributed
$67,178
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.7M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,075,208 · 4
By mechanism
UM1$11,008,030 · 1
P30$66,136 · 1
M01$1,042 · 2
Top collaborators
- Vicki Suzanne Klimberg4 shared
- Funda Meric-Bernstam4 shared
- James C Yao4 shared
- Anna Capasso3 shared
- S Gail Eckhardt1 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Peter J Houghton$32,798,876
- Sunil Sudarshan$4,229,836
- Muralidhar Beeram$5,402
- Anand Karnad$68,462
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyClinical ResearchReportingSafety StudyAdverse EventResearch DesignEnsureCancer CenterTumorClinically RelevantPharmacodynamicsPeripheral Blood Mononuclear CellClinical TrialsInstitutionEnrollmentDoseMalignant NeoplasmsResearch PersonnelBiologicalResponsePharmaceutical PreparationsBiopsyCollaborationsCommon Neoplasm
Grant awards (9)
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285
UM1 · FY2025 · CA
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285
UM1 · FY2024 · CA
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,952,013
UM1 · FY2023 · CA
Texas EXperimental Cancer Therapeutics Network - TEX CTN$5,697,447
UM1 · FY2020 · CA
DATA SAFETY AND MONITORING BOARDS$21,557
P30 · FY2011 · CA · contact PI
DATA SAFETY AND MONITORING BOARDS$22,092
P30 · FY2010 · CA · contact PI
DATA SAFETY AND MONITORING BOARDS$22,487
P30 · FY2009 · CA · contact PI
CLINICAL TRIAL: PH I PK STUDY OF TEMSIROLIMUS (CCI-779) IN PTS WITH IMPAIRED LIV$839
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PK AND BIOL STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) IN P$203
M01 · FY2008 · RR · contact PI